Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Toxicokinetics The sequence between exposure to a chemical and the generation of an adverse effect can be divided into two aspects 1. Toxicokinetics or the delivery of the compound to its site of action 2. Toxicodynamics or the response at the site of action. The Toxicological Paradigm Toxicokinetics • Toxicokinetics is the quantitation of the time course of toxicants in the body during the processes of absorption, distribution, biotransformation, and excretion or clearance of toxicants. In other words, toxicokinetics is a reflection of how the body handles toxicants as indicated by the plasma concentration of that xenobiotic at various time points • The end result of these toxicokinetic processes is a biologically effective dose of the toxicant. Toxicodynamics Toxicodynamics refers to the molecular, biochemical, and physiological effects of toxicants or their metabolites in biological systems These effects are result of the interaction of the biologically effective dose of the ultimate (active) form of the toxicant with a molecular target Molecular Targets Concept The toxic action of a chemical is a consequence of the physical/chemical interaction of the active form of that chemical with a molecular target within the living organism Molecular Targets Concept Reaction Types; Non Covalent Binding Covalent Binding Electron Transfer Enzymatic Reaction Outcomes; Dysfunction Destruction Neoantigen Formation Examples of Molecular Targets Proteins Arylhydrocarbon (Ah) receptor—Dioxin Hemoglobin—CO Lipids—Carbon tetrachloride DNA—Aflatoxin The Toxicological Process • Toxicokinetics is the study of the drug movement around the body (Absorption, Distribution, metabolism, and Elimination) • Toxicokinetic data is best derived using radio labeled dose of the drug. This allows for following the fate of the drug, metabolic products, distribution in the tissue, storage sites, as well as its elimination • Toxicokinetics is concerned with what the body does to the toxicant Disposition of Xenobiotics Ingestion Inhalation Intravenous Intraperitoneal Subcutaneous Gastrointestinal trac t Inhalation Lung Ingestion Intravenous Intramusc ular Intraperitoneal Subcutaneous Gastrointestinal tract Dermal Intramuscular Lung Dermal Liver Liver Blood and lymph Blood and lymph Bile Bile feces Kidney Lung Bladder Alveoli KidneyUrine Bladder feces Urine Secretory Structures extracellular fluid LungSecretions ex tracellular fluid body organs soft tissue Expired Air fat bone Secretory Structures body organs soft tis sue Alveoli Expired Air fat Secretions bone • The toxicokinetics of a chemical are determined by measuring the concentrations of the chemical in blood at various times following a single dose. The fundamental parameters that define the rates and extents of distribution and elimination are derived from data following an intravenous or oral dose. Important principles of Toxicokinetics • The effect which a drug produces is dependent on: 1. The dose 2. The concentration in the target organ • • The kinetics of a drug may differ from therapeutic dose to its toxic dose Toxicokinetics is important in predicting the plasma concentration of a drug Toxicokinetics and Toxicity Toxicity depends on: • Duration and concentration of drug at the portal of entry • The rate and amount (extent) of drug absorbed; toxicity will be low at slow absorption rates. This means that a highly toxic drug that is poorly absorbed may have same hazard as another with low toxicity but is highly absorbed. • The distribution of drug within the body; where most drugs are distributed in highly perfused organs like brain, liver and kidneys. However, in some cases, the organ in which the drug is concentrated may not necessarily suffer the damage. • An example is organochlorine compounds concentrated in adipose tissue while the target organ is the brain. • The efficiency of biotransformation and nature of metabolites; where, in some cases, a drug may be transformed to a more toxic metabolite or a more lipid soluble or water soluble metabolite, which affects absorption and distribution • The ability of the drug to pass through cell membranes and interact with cell constituents. Example, some organochlorines affect the DNA • The amount and storage duration of the drug or its metabolites in the tissue. These may induce toxicity after a long time after exposure. Lead in bones is an example • The rate and site of excretion; where the more rapid the excretion, the less toxicity it will produce